Table: begin end state 1 5 non-cytoplasmic 6 25 transmembrane 26 31 cytoplasmic 32 52 transmembrane 53 63 non-cytoplasmic 64 83 transmembrane 84 103 cytoplasmic 104 132 transmembrane 133 142 non-cytoplasmic 143 161 transmembrane 162 181 cytoplasmic 182 201 transmembrane 202 232 non-cytoplasmic 233 257 transmembrane 258 268 cytoplasmic 269 288 transmembrane 289 307 non-cytoplasmic 308 328 transmembrane 329 334 cytoplasmic 335 358 transmembrane 359 360 non-cytoplasmic 361 361 transmembrane 362 362 non-cytoplasmic 363 383 transmembrane 384 389 cytoplasmic 390 413 transmembrane 414 425 non-cytoplasmic 426 449 transmembrane 450 450 cytoplasmic
Input: >HSERO_RS08740 FitnessBrowser__HerbieS:HSERO_RS08740 MEAVQGSALLVYALVAVIALIVLIAKFKMNPFIVLIVVSLVLGLAVGMPMGNIVKAFETG VGNALGHIALVVGLGTMLGKMMAESGGAERIANTMIKAFGEKNVHWAMMTVAFIVGLPVF FEVGFVLLVPIAFNVAKRTGTNMVLVGIPMVAGLSVVHGLIPPHPAALLAVTAYSADIGR TILYALIVGIPTAIIAGPIFGKLISKVVIPNPDNPLISQFVDEGKKDRELPGFGITLFTI LLPVALMLIGSWADLFFAPKTFANDFLRLIGNSVIALLIATLVSFWTFGRARGFGADQIL KFTNECLAPIASITLVVGAGAGFGRILMDGGVSKAIVGIATDAHLSPLILGWFVAALIRV ATGSATVAMTTACGIVAPIVSTVGGVRPELMVLATGAGSLILSHVNDGGFWLVKEYFNMT VPQTFKTWTVMETLVSVLALLFTLALATVV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server